6
Oct
2026
Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026
stand 12F52
Book a meeting

Abzena

About Abzena

Abzena is the leading end-to-end complex biologics, bioconjugates (ADCs, AOCs, RDCs) & bispecifics CDMO + CRO. From early-stage discovery through commercial manufacturing, we support customers with fully integrated programs or individual services designed to de-risk and streamline the development of new medicines to patients.

Read more Show less
Certifications
  • FDA
    FDA
  • GMP
    GMP
  • ISO
    ISO
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less

Meet us at

  • CPHI Milan 2026

    CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
    stand 12F52
  • Country/Region:
    United Kingdom
  • Founded:
    2001
  • On CPHI since:
    2025
  • Certificates:
    3
  • Employees:
    250 - 499
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Pharmaceutical company
Primary activities
Contract Manufacturer
Contact info
Show contact info Hide contact info

Products from Abzena (5)

  • De-Risk Your Complex Biologic with Developability & Manufacturability Assessments

    Product De-Risk Your Complex Biologic with Developability & Manufacturability Assessments

    Abzena’s integrated approach to developability assessment ensures that your biologic or bioconjugate is not only viable but optimized for success. By continually refining our selection criteria and asking the right questions early, we de-risk projects and move closer to developing ideal drugs. Our stage-a...
  • Fully Integrated Development & Manufacturing Services for ADCs, AOCs, & RDCs

    Product Fully Integrated Development & Manufacturing Services for ADCs, AOCs, & RDCs

    Move your bioconjugate to patients faster with one fully integrated partner across linker-payload design & synthesis, highly potent API (HPAPI) development & manufacturing, & advanced bioconjugation services. With over 25 years of experience, 3,000+ conjugates developed, and 1,400+ linker-payloads desig...
  • GMP-Ready Mammalian Cell Line Development

    Product GMP-Ready Mammalian Cell Line Development

    GMP-ready, mammalian cell line development. Achieve stable pools in 3 weeks and accelerate from DNA to RCB in just 10 weeks & GMP in 6 months with up to 10g/L in high-performing titers. Abzena offers fully integrated stable pools to GMP manufacturing solutions with AbZelectPRO™, which is engineered for s...
  • Improved Design & Delivery of ADCs & AOCs with ThioBridge® Site-Specific Conjugation

    Product Improved Design & Delivery of ADCs & AOCs with ThioBridge® Site-Specific Conjugation

    Improve your ADC & AOC design and delivery with our ThioBridge® conjugation platform technology. Abzena's site-specific conjugation technology solution by provides a more uniform DAR & OAR profiles, stable linker attachment, and improved pharmacokinetic properties. ThioBridge® is important for the advance...
  • Smarter Immunogenicity Testing with EpiScreen®2.0

    Product Smarter Immunogenicity Testing with EpiScreen®2.0

    Avoid issues later in the drug development process with smarter immunogenicity testing that improves candidate selection, reduces risk, and supports confident development decisions. Our enhanced bioassay platform EpiScreen® 2.0, is a comprehensive suite of assays that predict and evaluate potential risks ...